As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
The Anatolian Journal of Cardiology
Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor [Anatol J Cardiol]
Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor
Marie-Camille Soucy-Giguere1, Éric Charbonneau2, Alexandre Cinq Mars1, Michelle Dubois3, Mario Sénéchal11Department of Cardiology, Quebec Heart and Lung Institute, Laval University; Quebec-Canada 2Department of Cardiovascular Surgery, Quebec Heart and Lung Institute, Laval University; Quebec-Canada 3Research Center, Quebec Heart and Lung Institute, Laval University; Quebec-Canada Keywords: Heart failure, TNF-alpha inhibitors, toxicity, LVAD
Marie-Camille Soucy-Giguere, Éric Charbonneau, Alexandre Cinq Mars, Michelle Dubois, Mario Sénéchal. Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor. Anatol J Cardiol. 2019; 22(1): 46-48
Corresponding Author: Mario Sénéchal, Canada Manuscript Language: English